Article · Wikipedia archive · Last revised Aug 1, 2026

MiraDry

miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis. It was approved by the US Food and Drug Administration (FDA) in 2011 and was also approved in Europe. miraDry selectively destroys axillary sweat glands without affecting the superficial layers of the skin. In addition to sweat glands, miraDry destroys hair follicles in the axillary region regardless of hair color. It is about 72.5 to 90% effective and sweat is reduced by about 82% on average. It also reduces axillary hair by about 75%. The effects of miraDry are noticeable almost immediately and are long-lasting or permanent. A case of death due to miraDry caused by necrotizing fasciitis that was complicated by streptococcal toxic shock syndrome has been reported.

Last revised
Aug 1, 2026
Read time
≈ 1 min
Length
267 w
Citations
10
Source
Wikipedia ↗

miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis.1 It was approved by the US Food and Drug Administration (FDA) in 2011 and was also approved in Europe.1 miraDry selectively destroys axillary sweat glands without affecting the superficial layers of the skin.1 In addition to sweat glands, miraDry destroys hair follicles in the axillary region regardless of hair color.1 It is about 72.5 to 90% effective2 and sweat is reduced by about 82% on average.3 It also reduces axillary hair by about 75%.4 The effects of miraDry are noticeable almost immediately and are long-lasting or permanent.1 A case of death due to miraDry caused by necrotizing fasciitis that was complicated by streptococcal toxic shock syndrome has been reported.56

References

References

  1. Gupta AK, Venkataraman M, Joshi LT, Cooper EA (November 2022). "Potential use of microwave technology in dermatology". J Dermatolog Treat. 33 (7): 2899–2910. doi:10.1080/09546634.2022.2089333. hdl:10026.1/19307. PMID 35699665.
  2. Arora G, Kassir M, Patil A, Sadeghi P, Gold MH, Adatto M, Grabbe S, Goldust M (January 2022). "Treatment of Axillary hyperhidrosis". J Cosmet Dermatol. 21 (1): 62–70. doi:10.1111/jocd.14378. PMID 34416078.
  3. Jacob C (March 2013). "Treatment of hyperhidrosis with microwave technology". Semin Cutan Med Surg. 32 (1): 2–8. PMID 24049923.
  4. "Home - miraDry" (PDF). corp.miradry.com. Retrieved 2025-08-12.
  5. Stam R (March 2024). "New developments in cosmetic applications of electromagnetic fields: Client and occupational hazard assessment". Bioelectromagnetics. doi:10.1002/bem.22503. PMID 38533721.
  6. Wen S, Unuma K, Makino Y, Mori H, Uemura K (September 2022). "Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome". Leg Med (Tokyo). 58 102095. doi:10.1016/j.legalmed.2022.102095. PMID 35662070.